SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-166678
Filing Date
2021-05-19
Accepted
2021-05-19 16:44:35
Documents
13
Period of Report
2021-05-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d165963d8k.htm   iXBRL 8-K 50762
  Complete submission text file 0001193125-21-166678.txt   213282

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amgn-20210518.xsd EX-101.SCH 4547
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20210518_def.xml EX-101.DEF 13773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20210518_lab.xml EX-101.LAB 22821
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20210518_pre.xml EX-101.PRE 14742
6 EXTRACTED XBRL INSTANCE DOCUMENT d165963d8k_htm.xml XML 6355
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 21940896
SIC: 2836 Biological Products, (No Diagnostic Substances)